Works matching IS 03065251 AND DT 2004 AND VI 57 AND IP 6

Results: 20

Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 807, doi. 10.1111/j.1365-2125.2003.02063.x
By:
- Tsuruoka, Shuichi;
- Wakaumi, Michi;
- Nishiki, Kenta;
- Araki, Nobutaka;
- Harada, Kenichi;
- Sugimoto, Koichi;
- Fujimura, Akio
Publication type:
Article
Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine mono phosphate challenge in persistent allergic rhinitis.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 714, doi. 10.1111/j.1365-2125.2004.02072.x
By:
- Lee, Daniel K. C.;
- Jackson, Catherine M.;
- Soutar, Patricia C.;
- Fardon, Thomas C.;
- Lipworth, Brian J.
Publication type:
Article
The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 773, doi. 10.1111/j.1365-2125.2004.02073.x
By:
- Sobue, Satoshi;
- Tan, Keith;
- Layton, Gary;
- Leclerc, Violette;
- Weil, Angelika
Publication type:
Article
Endothelins and their inhibition in the human skin microcirculation: ET[1−31], a new vasoconstrictor peptide.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 720, doi. 10.1111/j.1365-2125.2004.02074.x
By:
- Leslie, Stephen J.;
- Rahman, Mamun Q.;
- Denvir, Martin A.;
- Newby, David E.;
- Webb, David J.
Publication type:
Article
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 790, doi. 10.1111/j.1365-2125.2004.02075.x
By:
- Van Roon, E. N.;
- Jansen, T. L. Th. A.;
- Mourad, L.;
- Houtman, P. M.;
- Bruyn, G. A. W.;
- Griep, E. N.;
- Wilffert, B.;
- Tobi, H.;
- Brouwers, J. R. B. J.
Publication type:
Article
Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 756, doi. 10.1111/j.1365-2125.2004.02082.x
By:
- Urien, Sail;
- Lokiec, François
Publication type:
Article
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 735, doi. 10.1111/j.1365-2125.2004.02077.x
By:
- Trenque, T.;
- Simon, N.;
- Villena, I.;
- Chemla, C.;
- Quereux, C.;
- Leroux, B.;
- Jaussaud, R.;
- Rémy, G.;
- Dupouy, D.;
- Millart, H.;
- Pinon, J.-M.;
- Urien, S.
Publication type:
Article
Bisphosphonate use and subsequent prescription of acid suppressants.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 813, doi. 10.1111/j.1365-2125.2004.02078.x
By:
- Roughead, E. E.;
- McGeechan, K.;
- Sayer, G. P.
Publication type:
Article
Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 742, doi. 10.1111/j.1365-2125.2004.02079.x
By:
- Foster, David J. R.;
- Somogyi, Andrew A.;
- White, Jason M.;
- Bochner, Felix
Publication type:
Article
Handbook of Drug Interactions. A Clinical and Forensic Guide.
Published in:
2004
By:
- Flanagan, R. J.
Publication type:
Book Review
Relationship between Type A and B personality and debrisoquine hydroxylation capacity.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 785, doi. 10.1111/j.1365-2125.2004.02076.x
By:
- Gan, S. H.;
- Ismail, R.;
- Adnan, W. A. Wan;
- Zulmi, W.;
- Kumaraswamy, N.;
- Larmie, E. T.
Publication type:
Article
Maximum a posteriori Bayesian estimation of epirubicin clearance by limited sampling.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 764, doi. 10.1111/j.1365-2125.2004.02084.x
By:
- Raiph, Lorraine D.;
- Thomson, Alison H.;
- Dobbs, Nicola A.;
- Twelves, Chris
Publication type:
Article
Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 798, doi. 10.1111/j.1365-2125.2004.02086.x
By:
- Deplanque, Dominique;
- Leys, Didier;
- Parnetti, Lucilla;
- Schmidt, Reinhold;
- Ferro, Jose;
- De Reuck, Jacques;
- Mas, Jean-Louis;
- Gallai, Virgilio
Publication type:
Article
The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 726, doi. 10.1111/j.1365-2125.2004.02088.x
By:
- Ohashi, Naro;
- Uematsu, Toshihiko;
- Nagashima, Satoru;
- Kanamaru, Mitsutaka;
- Togawa, Akashi;
- Hishida, Akira;
- Uchida, Eiji;
- Akizawa, Tadao;
- Koshikawa, Shozo
Publication type:
Article
The revision of the Declaration of Helsinki: past, present and future.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 695, doi. 10.1111/j.1365-2125.2004.02103.x
By:
- Carlson, Robert V.;
- Boyd, Kenneth M.;
- Webb, David J.
Publication type:
Article
Quinine intoxications: a continuing problem.
Published in:
2004
By:
- Taylor, S.
Publication type:
Letter
On the waterfront – the breadth and depth of clinical pharmacology.
Published in:
2004
By:
- Aronson, J. K.
Publication type:
Editorial
Announcements.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 819, doi. 10.1111/j.1365-2125.2004.02165.x
Publication type:
Article
Author index.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 820, doi. 10.1111/j.1365-2125.2004.02166.x
Publication type:
Article
Subject index.
Published in:
British Journal of Clinical Pharmacology, 2004, v. 57, n. 6, p. 830, doi. 10.1111/j.1365-2125.2004.02167.x
Publication type:
Article

Works matching IS 03065251 AND DT 2004 AND VI 57 AND IP 6

Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects.

Effects of single or combined histamine H<sub>1</sub>-receptor and leukotriene CysLT<sub>1</sub>-receptor antagonism on nasal adenosine mono phosphate challenge in persistent allergic rhinitis.

The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.

Endothelins and their inhibition in the human skin microcirculation: ET<sub>[1−31]</sub>, a new vasoconstrictor peptide.

Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.

Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.

Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.

Bisphosphonate use and subsequent prescription of acid suppressants.

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

Handbook of Drug Interactions. A Clinical and Forensic Guide.

Relationship between Type A and B personality and debrisoquine hydroxylation capacity.

Maximum a posteriori Bayesian estimation of epirubicin clearance by limited sampling.

Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.

The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.

The revision of the Declaration of Helsinki: past, present and future.

Quinine intoxications: a continuing problem.

On the waterfront – the breadth and depth of clinical pharmacology.

Announcements.

Author index.

Subject index.